SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027766
Filing Date
2013-05-10
Accepted
2013-05-10 12:08:04
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v342576_10q.htm 10-Q 334711
2 EX-31.1 v342576_ex31-1.htm EX-31.1 9776
3 EX-31.2 v342576_ex31-2.htm EX-31.2 10263
4 EX-32.1 v342576_ex32-1.htm EX-32.1 6450
5 EX-32.2 v342576_ex32-2.htm EX-32.2 6281
  Complete submission text file 0001144204-13-027766.txt   1785952

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20130331.xml EX-101.INS 117565
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20130331.xsd EX-101.SCH 22253
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20130331_cal.xml EX-101.CAL 33555
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20130331_def.xml EX-101.DEF 99109
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20130331_lab.xml EX-101.LAB 184770
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20130331_pre.xml EX-101.PRE 124665
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 13831997
SIC: 2836 Biological Products, (No Diagnostic Substances)